Finance Home - My Yahoo - Yahoo! - Help

Wednesday, December 30, 2009, 11:06PM ET - U.S. Markets Closed. Dow  0.03% Nasdaq  0.13%

SHIRE (SHP.L)

At 11:35AM ET: 1,208.00   8.00 (0.66%)

MORE ON SHP.L

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Tue, Dec 22, 2009 • Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA) PR Newswire (Tue, Dec 22) Thu, Dec 3, 2009 • Hepatitis C drug fights virus in new way at Reuters (Thu, Dec 3) Wed, Dec 2, 2009 • Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic PR Newswire (Wed, Dec 2) Tue, Dec 1, 2009 • UPDATE - Pfizer acquires rights to Protalix's Gaucher drug at Reuters (Tue, Dec 1) Tue, Nov 24, 2009 • Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease PR Newswire (Tue, Nov 24) Thu, Nov 12, 2009 • Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII PR Newswire (Thu, Nov 12) Wed, Nov 11, 2009 • Shire Re-Launches FOCUS, an Online, Personalized Patient Support Program for Adults with ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII PR Newswire (Wed, Nov 11) Mon, Nov 9, 2009 • Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide PR Newswire (Mon, Nov 9) Wed, Nov 4, 2009 • Shire Extends Agreement with Medidata Solutions for Trial Planning Products Business Wire (Wed, Nov 4) • FDA Grants Priority Review for Shire's velaglucerase alfa for Type 1 Gaucher Disease PR Newswire (Wed, Nov 4) Mon, Nov 2, 2009 • New Shire Board Member PR Newswire (Mon, Nov 2) Fri, Oct 30, 2009 • Shire Plc Earnings Call scheduled for 10:00 am ET today CCBN (Fri, Oct 30) • Shire Continues to Deliver Excellent Growth From Core Products PR Newswire (Fri, Oct 30) • Q3 2009 Shire Plc Earnings Release - 08:00 am ET CCBN (Fri, Oct 30) Thu, Oct 29, 2009 • New Data Show Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using the Oppositional Subscale of the Conners' ADHD Rating Scale PR Newswire (Thu, Oct 29) • Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30 PR Newswire (Thu, Oct 29) Wed, Oct 28, 2009 • Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease PR Newswire (Wed, Oct 28) Mon, Oct 26, 2009 • FDA Determines VYVANSE(R) was Properly Granted Five-Year Market Exclusivity PR Newswire (Mon, Oct 26) Thu, Oct 22, 2009 • New Study on Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII Shows Administration of Vyvanse Through Two Different Routes Demonstrated a Similar Pharmacokinetic Profile PR Newswire (Thu, Oct 22) Wed, Oct 21, 2009 • Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA PR Newswire (Wed, Oct 21) Older Headlines - Download Recent Headlines View headlines from: Wed, Oct 21, 2009Wed, Oct 14, 2009Wed, Oct 7, 2009Wed, Sep 30, 2009Wed, Sep 23, 2009Wed, Sep 16, 2009Wed, Sep 9, 2009Wed, Sep 2, 2009Wed, Aug 26, 2009Wed, Aug 19, 2009 Add SHP.L News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage